Torben A. Kruse

4.5k total citations
8 papers, 212 citations indexed

About

Torben A. Kruse is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Torben A. Kruse has authored 8 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Torben A. Kruse's work include BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (3 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Torben A. Kruse is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (3 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Torben A. Kruse collaborates with scholars based in Denmark, Sweden and Germany. Torben A. Kruse's co-authors include Anne‐Marie Gerdes, Mads Thomassen, Peder Madsen, Hans Christian Thøgersen, Hans Jürgen Hoffmann, Julio E. Celis, Eydfinnur Olsen, Michael Etzerodt, Dorthe Gylling Crüger and Peter K.A. Jensen and has published in prestigious journals such as FEBS Letters, Journal of Investigative Dermatology and Breast Cancer Research and Treatment.

In The Last Decade

Torben A. Kruse

8 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torben A. Kruse Denmark 6 144 102 42 39 22 8 212
Ziliang Ji China 7 189 1.3× 29 0.3× 127 3.0× 31 0.8× 6 0.3× 9 290
Heidi Giese United States 8 282 2.0× 48 0.5× 106 2.5× 15 0.4× 6 0.3× 10 369
Charles Joly Beauparlant Canada 9 172 1.2× 76 0.7× 79 1.9× 28 0.7× 18 0.8× 21 258
Khemais Benhaj Tunisia 7 301 2.1× 51 0.5× 49 1.2× 21 0.5× 4 0.2× 9 384
Yonghui Zhao China 8 143 1.0× 40 0.4× 27 0.6× 20 0.5× 4 0.2× 25 235
Osamu Miyoshi Japan 11 176 1.2× 116 1.1× 16 0.4× 20 0.5× 13 0.6× 22 278
Akshada Gajbhiye India 8 162 1.1× 13 0.1× 22 0.5× 25 0.6× 11 0.5× 12 244
Michaël Jeanblanc France 7 401 2.8× 69 0.7× 40 1.0× 34 0.9× 9 0.4× 7 484
Jianli Wu China 9 126 0.9× 44 0.4× 73 1.7× 36 0.9× 3 0.1× 16 390
Kyle T. Powers United States 10 271 1.9× 47 0.5× 79 1.9× 16 0.4× 4 0.2× 13 339

Countries citing papers authored by Torben A. Kruse

Since Specialization
Citations

This map shows the geographic impact of Torben A. Kruse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben A. Kruse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben A. Kruse more than expected).

Fields of papers citing papers by Torben A. Kruse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torben A. Kruse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben A. Kruse. The network helps show where Torben A. Kruse may publish in the future.

Co-authorship network of co-authors of Torben A. Kruse

This figure shows the co-authorship network connecting the top 25 collaborators of Torben A. Kruse. A scholar is included among the top collaborators of Torben A. Kruse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torben A. Kruse. Torben A. Kruse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lænkholm, Anne‐Vibeke, Maj‐Britt Jensen, Jens Ole Eriksen, et al.. (2017). Clinical and molecular characterization ofBRCA-associated breast cancer: results from the DBCG. Acta Oncologica. 57(1). 95–101. 13 indexed citations
2.
Thomassen, Mads, Inge Søkilde Pedersen, Ida Vogel, et al.. (2010). A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing. Breast Cancer Research and Treatment. 128(1). 179–185. 4 indexed citations
3.
Thomassen, Mads, Thomas van Overeem Hansen, Åke Borg, et al.. (2008). BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncologica. 47(4). 772–777. 36 indexed citations
4.
Thomassen, Mads, Anne‐Marie Gerdes, Dorthe Gylling Crüger, Peter K.A. Jensen, & Torben A. Kruse. (2006). Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genetics and Cytogenetics. 168(2). 168–171. 40 indexed citations
5.
Thomassen, Mads, Torben A. Kruse, Karen Ege Olsen, Alexander Borg, & Anne‐Marie Gerdes. (2004). Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. Breast Cancer Research and Treatment. 87(3). 273–276. 2 indexed citations
6.
Hoffmann, Hans Jürgen, Eydfinnur Olsen, Michael Etzerodt, et al.. (1994). Psoriasin Binds Calcium and Is Upregulated by Calcium to Levels that Resemble Those Observed in Normal Skin. Journal of Investigative Dermatology. 103(3). 370–375. 77 indexed citations
7.
Tønnesen, T., et al.. (1992). Multipoint linkage analysis in Menkes disease.. PubMed. 50(5). 1012–7. 23 indexed citations
8.
Kruse, Torben A., Lars Bolund, Karl‐Heinz Grzeschik, et al.. (1988). Assignment of the human aminopeptidase N (peptidase E) gene to chromosome 15q13‐qter. FEBS Letters. 239(2). 305–308. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026